Search

Your search keyword '"Mitjavila, F."' showing total 3 results
Start Over Author "Mitjavila, F." Journal medicina clinica
3 results on '"Mitjavila, F."'

1. [Granulomatous mastitis associated with erythema nodosum: A case series of 42 patients].

Author

Moreno-Vílchez C, Llobera-Ris C, Penin RM, Pla MJ, Mitjavila F, and Marcoval J

Subjects
Female, Humans, Research, Retrospective Studies, Breast Neoplasms, Erythema Nodosum diagnosis, Granulomatous Mastitis complications, Granulomatous Mastitis diagnosis
Abstract

Background: Granulomatous mastitis (GM) is defined by the formation of granulomatous inflammation in breast tissue. Erythema nodosum (EN) is a reactive inflammatory panniculitis characterized by erythematous subcutaneous nodules in the lower limbs. The association of GM with EN has been rarely reported. Our aim was to retrospectively review our series of patients with GM to better characterize their features and their association with EN., Methods: Cases histologically diagnosed as granulomatous inflammation in breast tissue between 1995 and 2020 were retrospectively reviewed., Results: Forty-two women were diagnosed with GM. The average age at diagnosis was 41.619years, and 59.5% were of South-American ethnicity. EN was associated with GM in 11.9% of the patients. Patients with EN were diagnosed earlier than isolated GM (0.4months vs 6.81months; P<.05). Ulceration in the GM was more prevalent in patients with associated EN (60% vs 14.7%; P<.05)., Conclusion: EN in patients with GM may reduce the evolution time and may help to diagnose this rare condition that mimics breast carcinoma., (Copyright © 2021 Elsevier España, S.L.U. All rights reserved.)

Published
2022
Full Text
View/download PDF

2. [Proliferative mesangial lupus nephritis: description of a cohort of 27 patients].

Author

Rubio-Rivas M, Gómez-Junyent J, Simonetti A, Mitjavila F, Capdevila O, and Pujol R

Subjects
Adolescent, Adult, Disease Progression, Drug Administration Schedule, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Lupus Nephritis diagnosis, Lupus Nephritis mortality, Male, Middle Aged, Prognosis, Retrospective Studies, Severity of Illness Index, Treatment Outcome, Young Adult, Anti-Inflammatory Agents therapeutic use, Immunosuppressive Agents therapeutic use, Lupus Nephritis drug therapy, Prednisone therapeutic use
Abstract

Background and Objective: To describe our cohort of 27 biopsy-proven patients and their long-term follow-up, with special attention to prognostic factors., Patients and Methods: Twenty seven patients were retrospectively collected. They were controlled in the Internal Medicine Department of the Bellvitge's Hospital (Spain) between 1974 and 2010. Evaluation was performed at one, 3 and 5 year follow-up., Results: There were 22 women (81.5%). Mean age at onset of nephritis was 34.83 years (SD 13.45). Partial or complete remission was achieved by 21 patients (80.77%) in the one-year follow-up, 22 patients (84.61%) in the third-year follow-up and 21 patients (77.77%) in the fifth-year follow-up. A change in the histology class was diagnosed in 4 patients. Seven patients suffered flares of nephritis. Seven patients died in the long term follow-up, 3 out of this 7 died because of systemic erythematosus lupus., Conclusion: Nephritis onset beyond 45 years old is the factor mostly related with a poor prognosis. That is the reason why we recommend co-therapy with immunosuppressors from the beginning in such patients., (Copyright © 2011 Elsevier España, S.L. All rights reserved.)

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results